Related Experiment Video
Updated: Oct 18, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Importance of diabetes management during the COVID-19 pandemic
1University of California, School of Medicine, San Diego, CA, USA.
Insights
Primary care physicians are crucial for managing diabetes and hyperglycemia in patients with COVID-19. Maintaining glycemic control is vital to reduce severe outcomes and mortality associated with the virus.
Area of Science:
- Endocrinology
- Infectious Diseases
- Primary Care Medicine
Background:
- Uncontrolled diabetes and hyperglycemia significantly increase COVID-19 severity and mortality risk.
- Poor glucose control pre-hospitalization correlates with higher in-hospital death rates.
- Primary care physicians (PCPs) are essential in managing glycemic control to mitigate COVID-19 complications.
Purpose of the Study:
- To review current knowledge on diabetes, hyperglycemia, and COVID-19 risks and outcomes.
- To provide guidance for PCPs on managing diabetic patients during the COVID-19 pandemic.
- To emphasize the role of glucose control, telemedicine, and online prescriptions.
Main Methods:
- Literature review of existing research on COVID-19 and diabetes.
- Synthesis of information relevant to the primary care setting.
- Focus on practical advice for PCPs.
Main Results:
- COVID-19 poses severe risks to individuals with diabetes, particularly those with poor glycemic control.
- PCPs face increasing numbers of patients with diabetes experiencing COVID-19 infection, post-COVID symptoms, or new-onset diabetes.
- Telemedicine and online prescription delivery are valuable tools for managing these patients.
Conclusions:
- Effective glucose control is paramount for improving outcomes in diabetic patients with COVID-19.
- PCPs require specific guidance to address the unique challenges posed by COVID-19 in diabetic populations.
- Proactive management strategies, including telemedicine, are crucial for limiting the impact of COVID-19 on individuals with hyperglycemia.
Abstract:
Uncontrolled diabetes and/or hyperglycemia is associated with severe COVID-19 disease and increased mortality. It is now known that poor glucose control before hospital admission can be associated with a high risk of in-hospital death. By achieving and maintaining glycemic control, primary care physicians (PCPs) play a critical role in limiting this potentially devastating outcome. Further, despite the hope that mass vaccination will help control the pandemic, genetic variants of the virus are causing surges in some countries. As such, PCPs will treat an increasing number of patients with diabetes who have symptoms of post-COVID-19 infection, or even have new-onset type 2 diabetes as a result of COVID-19 infection. However, much of the literature published focuses on the effects of COVID-19 in hospitalized patients, with few publications providing information and advice to those caring for people with diabetes in the primary care setting. This manuscript reviews the current knowledge of the risk and outcomes of individuals with diabetes who are infected with COVID-19 and provides information for PCPs on the importance of glucose control, appropriate treatment, and use of telemedicine and online prescription delivery systems to limit the potentially devastating effects of COVID-19 in people with hyperglycemia.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

